Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Langfitt

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Comprehensive Therapy|December 1, 1984
Drugs and the liverB E Kolts, M Langfitt
Infection and Immunity|August 24, 2011
Resistance to Yersinia pestis infection decreases with age in B10.T(6R) miceNathaniel D Lambert, Deanna M Langfitt, Matthew L Nilles, et al.
Nature Medicine|January 19, 2023
One Health interprofessional stewardship to combat antimicrobial resistanceAmy M Sjoberg, Claire L Fellman, Ian M DeStefano, et al.
Molecular Therapy. Methods & Clinical Development|June 17, 2024
Genetic alteration of SJ293TS cells and modification of serum-free media enhances lentiviral vector productionMatthew Bauler, Francesca Ferrara, Brandon Lowe, et al.
Cell Reports. Medicine|February 13, 2024
Peptide-scFv antigen recognition domains effectively confer CAR T cell multiantigen specificityJaquelyn T Zoine, Kalyan Immadisetty, Jorge Ibanez-Vega, et al.
Journal of Virology|January 10, 2025
Modulation of cytokeratin and cytokine/chemokine expression following influenza virus infection of differentiated human tonsillar epithelial cellsS Scott Perry, David C Brice, Ahmed Atef Sakr, et al.
Biorxiv : the Preprint Server for Biology|June 6, 2025
Targeting Regnase-1 unleashes CAR T cell antitumor activity for osteosarcoma and creates a proinflammatory tumor microenvironmentAdeleye O Adeshakin, Hao Shi, S Scott Perry, et al.
Blood|August 1, 2022
Engineering naturally occurring CD7- T cells for the immunotherapy of hematological malignanciesAbdullah Freiwan, Jaquelyn T Zoine, Jeremy Chase Crawford, et al.
Science Advances|October 6, 2023
Integrome signatures of lentiviral gene therapy for SCID-X1 patientsKoon-Kiu Yan, Jose Condori, Zhijun Ma, et al.
Science Translational Medicine|November 17, 2021
Deleting DNMT3A in CAR T cells prevents exhaustion and enhances antitumor activityBrooke Prinzing, Caitlin C Zebley, Christopher T Petersen, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Comprehensive Therapy|December 1, 1984
Drugs and the liverB E Kolts, M Langfitt
Infection and Immunity|August 24, 2011
Resistance to Yersinia pestis infection decreases with age in B10.T(6R) miceNathaniel D Lambert, Deanna M Langfitt, Matthew L Nilles, et al.
Nature Medicine|January 19, 2023
One Health interprofessional stewardship to combat antimicrobial resistanceAmy M Sjoberg, Claire L Fellman, Ian M DeStefano, et al.
Molecular Therapy. Methods & Clinical Development|June 17, 2024
Genetic alteration of SJ293TS cells and modification of serum-free media enhances lentiviral vector productionMatthew Bauler, Francesca Ferrara, Brandon Lowe, et al.
Cell Reports. Medicine|February 13, 2024
Peptide-scFv antigen recognition domains effectively confer CAR T cell multiantigen specificityJaquelyn T Zoine, Kalyan Immadisetty, Jorge Ibanez-Vega, et al.
Journal of Virology|January 10, 2025
Modulation of cytokeratin and cytokine/chemokine expression following influenza virus infection of differentiated human tonsillar epithelial cellsS Scott Perry, David C Brice, Ahmed Atef Sakr, et al.
Biorxiv : the Preprint Server for Biology|June 6, 2025
Targeting Regnase-1 unleashes CAR T cell antitumor activity for osteosarcoma and creates a proinflammatory tumor microenvironmentAdeleye O Adeshakin, Hao Shi, S Scott Perry, et al.
Blood|August 1, 2022
Engineering naturally occurring CD7- T cells for the immunotherapy of hematological malignanciesAbdullah Freiwan, Jaquelyn T Zoine, Jeremy Chase Crawford, et al.
Science Advances|October 6, 2023
Integrome signatures of lentiviral gene therapy for SCID-X1 patientsKoon-Kiu Yan, Jose Condori, Zhijun Ma, et al.
Science Translational Medicine|November 17, 2021
Deleting DNMT3A in CAR T cells prevents exhaustion and enhances antitumor activityBrooke Prinzing, Caitlin C Zebley, Christopher T Petersen, et al.
Pageof 1